在患有新发性狼性炎的儿童中,使用贝利马布的持续性反应
Ren Wang1, Tao Sun2, Zhuo Shi2
1Department of Pediatrics, Jinling Hospital, Nanjing Medical University, Nanjing, China.
Journal of nephrology
|November 13, 2025
概括
在儿科狼性炎 (LN) 中使用贝利马布治疗改善了脏反应,并减少了发作. 这种生物制剂在患有LN的儿童中保持长期功能方面表现有前途.
科学领域:
- 儿科脏病学 儿科脏病学
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 贝利马布已被批准用于儿科系统性红斑狼 (SLE),但需要在这个人群中进一步验证疗效和安全性.
- 儿科狼性炎 (LN) 需要评估长期治疗对反应和疾病爆发的影响.
研究的目的:
- 评估贝利穆马布对儿科LN持续性反应的影响.
- 评估贝利穆马布对患有LN的儿童疾病爆发率的影响.
- 根据临床决策对儿科LN使用belimumab的信息.
主要方法:
- 一项前性队列研究包括96名患有LN的儿童.
- 患者被分为贝利马布组 (68) 和标准治疗组 (28).
- 在152周的时间内,研究小组之间的缓解率,复发率和不良事件进行了比较.
主要成果:
- 贝利马布增加了16.7%的功能响应和24.7%的完全功能响应.
- 与标准治疗相比,贝利马布组的LN爆发率降低了46.2%.
- 长期完全缓解率没有显著差异 (P=0.081),但标准治疗组的复发率更高 (P=0.004).
结论:
- 将贝利穆马布添加到标准治疗中,可能会在儿科LN中保持长期的功能.
- 贝利马布似乎是一种有效和安全的生物药物,可以减少LN爆发.
- 这些发现支持belimumab在治疗儿科狼性炎中的作用.
相关概念视频
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
197
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
197
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
254
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
254